ICVX | Icosavax, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	15.28 - 15.44
52 Week Range	4.75 - 16.11
Beta	1.42
Implied Volatility	274.58%
IV Rank	0.62%
Day's Volume	8,556,852
Average Volume	1,053,296
Shares Outstanding	50,231,000
Market Cap	769,036,610
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-07-29

Valuation
Profitability
Growth
Health
P/E Ratio	-6.96
Forward P/E Ratio	-3.67
EPS	-2.20
1YR Price Target	50.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	60
Country	USA
Website	ICVX

Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases that address important unmet medical needs to save lives and improve health.

ICVX's peers: ABSI, ACHV, ACIU, AGEN, ALLO, ANNX, ARQT, ATRA, BHVN, PMCB, BPTH, BRTX, CGEN, CNTX, CRBP, CRNX, EXAI, HUMA, IFRX, INAB, IPA, ITOS, JSPR, LGND, MIRM, MRKR, NBTX, NERV, OMER, PGEN, PYXS, RCUS, SLNO, SMMT, SYBX, TCRX, TLSA, UBX, VCYT, VRDN, VTGN, WVE, XBIT, YMAB, ZNTL, IVVD, ERNA, SPRY

*Chart delayed

Analyzing fundamentals for ICVX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see ICVX Fundamentals page.

Watching at ICVX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on ICVX Technicals page.